SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending amid widespread discussion and conflicting reports regarding a major deal with AI chip startup Groq, debated as either a $20 billion acquisition or a strategic licensing agreement. The community is sharply divided, with bulls touting it as a genius move to solidify NVIDIA's dominance in AI inference and talent acquisition, while bears decry it as a desperate, overpriced gambit. This strategic play aims to further cement NVIDIA's leadership across the entire AI hardware lifecycle, from training to the increasingly crucial inference market.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending as community sentiment is fueled by technical indicators like anticipated "golden crosses" and calls for a significant breakout. Recent reports of users moving their coins to self-custody wallets due to security concerns and exchange transfer issues are also driving conversation. While many expect a rally for the "digital silver," others remain skeptical of its current performance.

Ethereum Classic

Ethereum Classic ($ETC) is trending amidst intense community debate, fueled by recent price volatility and its surprising appearance as a top trending asset. Many long-term holders express deep frustration over its sustained underperformance compared to other major cryptocurrencies, while a segment of the community remains strongly bullish, viewing current price levels as a significant discount and a "loading zone" before an anticipated breakout.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs and upcoming Chinese export restrictions. This rally is further fueled by booming industrial demand from EV batteries, solar, and AI data centers, sparking community debate over a potential 'silver squeeze' versus an impending sharp pullback.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending following the significant FDA approval of YARTEMLEA, making it the first and only approved treatment for a life-threatening post-transplant complication in both adults and children. The community is actively discussing the drug's blockbuster potential due to its lack of competition and the company's validated pipeline, alongside hopes for a short squeeze and potential buyout speculation, particularly from existing partner Novo Nordisk. Excitement is building ahead of the upcoming conference call where further details, including pricing, are anticipated.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following recent analyst upgrades and price target increases, with its CEO's media appearances highlighting key partnerships like OpenTable and potential future announcements at CES 2026. The community is engaged in a polarized discussion, weighing the company's "Agentic AI" technology, robust revenue growth, and zero-debt status against persistent short interest and recent price underperformance. Despite the division, many foresee significant long-term growth as the company expands its voice AI solutions across various sectors.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is a major trending topic as significant options expirations are driving notable short-term volatility and ongoing price debate. The community remains divided, with many bulls anticipating a strong breakout and long-term institutional accumulation once expiration pressure subsides, while bears highlight persistent selling pressure and perceived market manipulation.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

BITO is a focal point of conversation as investors anticipate its substantial monthly dividend, with many actively buying on recent dips and viewing current volatility as an accumulation opportunity. The community widely discusses the ETF's dividend payout in relation to its price movements around the ex-dividend date, while maintaining a long-term bullish outlook on Bitcoin's potential for future highs amid ongoing institutional adoption.

Boundless is a universal protocol that brings ZK to every chain. Using Boundless, developers can create expressive, high-throughput applications that bypass traditional block size/gas limits.  Developers submit proof requests and provers compete to fulfill them, earning direct rewards and protocol-level incentives through proof of verifiable work.  By abstracting away the complexity of proof generation, aggregation, and onchain settlement, Boundless allows developers to build without worrying about underlying infrastructure, while provers provide strong liveness guarantees, censorship-resistance, and continuously improve the cost curve driven by open market dynamics.  This architecture decouples execution from consensus and introduces a new paradigm for verifiable computing. As the number of Boundless prover nodes grows, the total capacity of the protocol increases, scaling compute across every chain.

Boundless

ZKC is trending due to its recently launched mainnet, positioning it as a key Ethereum scaling solution aiming to capture market share from competitors. The community is actively discussing its potential for a major reversal and breakout, while simultaneously debating concerns over recent price action and perceived lack of sustained volume.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

The Defiance Daily Target 2X Long SMCI ETF ($SMCX) is trending amid strong bullish sentiment for its underlying asset, Super Micro Computer ($SMCI), driven by positive news like Nvidia's China chip shipments and significant AI infrastructure investments. Traders are actively debating its extreme volatility and decay concerns, with many viewing current price levels as a "buy the dip" opportunity for substantial gains as they anticipate an AI sector rally.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat...

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4% - Here's Why

DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 7.4% - Here's Why...

DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year High - Time to Buy?

DiaMedica Therapeutics (NASDAQ:DMAC) Hits New 1-Year High - Here's What Happened...

Jan Stahlberg Buys 128,426 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of the business's stock in a transaction that occurred on Thursday, November 20th...

Jan Stahlberg Acquires 73,099 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 73,099 shares of DiaMedica Therapeutics stock in a transaction that occurred on Tuesday, November...

Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of DiaMedica Therapeutics stock in a transaction dated Thursday, November 20th...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 182,882 shares of the company's stock in a transaction that occurred on Tuesday, November 18th. The...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,221,802.36 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 187,393 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The...

Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 208,872 shares of the business's stock in a transaction dated Friday, November 21st. The stock was...

Jan Stahlberg Acquires 240,352 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 240,352 shares of the firm's stock in a transaction on Wednesday, November 19th. The stock was...

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.18	--	--	N/A
Q3 '25	-$0.16	-$0.17	-6.25%	MISSED
Q2 '25	-$0.19	-$0.18	5.26%	BEAT
Q1 '25	-$0.18	-$0.18	--	EXPECTED
Q4 '24	-$0.17	-$0.18	-4.35%	MISSED

DMAC
DiaMedica Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest DMAC News

DMACDiaMedica Therapeutics Inc